Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease

Parkinson’s disease (PD) is a chronic and progressive disorder characterized neuropathologically by loss of dopamine neurons in the substantia nigra, intracellular proteinaceous inclusions, reduction of dopaminergic terminals in the striatum, and increased neuroinflammatory cells. The consequent red...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramaniam, Sudhakar R., Federoff, Howard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463358/
https://www.ncbi.nlm.nih.gov/pubmed/28642697
http://dx.doi.org/10.3389/fnagi.2017.00176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463358/
https://www.ncbi.nlm.nih.gov/pubmed/28642697
http://dx.doi.org/10.3389/fnagi.2017.00176

Ejemplares similares